Harnessing the Power of Implementation Science to Improve the Quality of Care for Oral Anticancer Therapies
- 1 September 2024
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 20 (9) , 1149-1151
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Trends and prescribing patterns of oral anti-neoplastic drugs: a retrospective longitudinal studyFrontiers in Public Health, 2023
- The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer AgentsJournal of Clinical Oncology, 2021
- Understanding and applying the RE-AIM framework: Clarifications and resourcesJournal of Clinical and Translational Science, 2021
- Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents: a randomized, multicenter controlled trial (ETICCO study)Supportive Care in Cancer, 2021
- What Can Implementation Science Do for You? Key Success Stories from the FieldJournal of General Internal Medicine, 2020
- Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping ReviewJNCI: Journal of the National Cancer Institute, 2020
- Harnessing the Synergy Between Improvement Science and Implementation Science in Cancer: A Call to ActionJournal of Oncology Practice, 2018
- Standards for Reporting Implementation Studies (StaRI): explanation and elaboration documentBMJ Open, 2017
- Using Implementation Science to Examine the Impact of Cancer Survivorship Care PlansJournal of Clinical Oncology, 2016
- 2013 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards Including Standards for the Safe Administration and Management of Oral ChemotherapyJournal of Oncology Practice, 2013